Effect of G-CSFR expression in bladder cancer
Effect of G-CSFR expression in bladder cancer
批准号:
6823896
负责人:
ARUP CHAKRABORTY
金额:
$13.12万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2006-07-31
关键词:
biological signal transductionbiomarkerbladder neoplasmcell growth regulationcell linecell migrationcell proliferationcolony stimulating factorgene expressiongenetic regulationgenetically modified animalsgrowth factor receptorsintermolecular interactionlaboratory mousemetastasismicroarray technologymolecular oncologyneoplasm /cancer geneticsprotein structure function
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): An increasing number of molecular markers are being identified that correlate with cancer metastasis or a poor prognosis. Typically these markers were examined based on the potential for a biologic activity that would act to enhance cancer cell growth and metastasis. There are also reports of various cytokine or growth factor receptors that are constitutively activated via autocrine or paracrine loops thus supporting cancer cell growth. While granulocyte colony-stimulating factor (G-CSF) expression has been shown for a wide variety of cancer cell types, an increasing number of reports are being published regarding the aberrant expression of the G-CSF receptor (G-CSFR) by various non-hematopoietic human cancers and cancer cell lines. Our aim is to clearly demonstrate that G-CSF expression coupled with aberrant G-CSFR expression by transitional cell carcinoma (TCC) can be used as a predictor of more aggressive behavior. We will demonstrate the biological impact of G-CSF/G-CSFR expression in in vitro and also in vivo by using a murine TCC model. Thus the aberrant G-CSFR expression that is being demonstrated by an expanding variety of solid tumors may serve as both a marker of specific tumor cell capabilities impacting clinical outcome and as a mechanism for many of these tumor-enhancing functions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of G-CSFR expression in bladder cancer
-
批准号:6929878
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2004
-
负责人:ARUP CHAKRABORTY
-
依托单位:
STAT3 AND G-CSF MEDIATED MYELOID DIFFERENTIATION
-
批准号:6077888
-
项目类别:
-
资助金额:$0.46万
-
财政年份:1999
-
负责人:ARUP CHAKRABORTY
-
依托单位:
STAT3 AND G-CSF MEDIATED MYELOID DIFFERENTIATION
-
批准号:6439430
-
项目类别:
-
资助金额:$4.09万
-
财政年份:1999
-
负责人:ARUP CHAKRABORTY
-
依托单位:
STAT3 AND G-CSF MEDIATED MYELOID DIFFERENTIATION
-
批准号:2640859
-
项目类别:
-
资助金额:$2.69万
-
财政年份:1998
-
负责人:ARUP CHAKRABORTY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
-
批准号:61602201
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2016
-
负责人:周雄辉
-
依托单位:
生物标志物NGAL和KIM-1分子在急性肾损伤中的作用机制研究及标志物联合检测对早期诊断AKI的作用
-
批准号:81101308
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:李海霞
-
依托单位:
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
-
批准号:81170309
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2011
-
负责人:颜桥
-
依托单位:
精神分裂症记忆障碍的脑网络组学研究
-
批准号:91132301
-
项目类别:重大研究计划
-
资助金额:350.0万元
-
批准年份:2011
-
负责人:蒋田仔
-
依托单位:
卵巢癌血浆microRNA潜在标志物筛选及调控机制研究
-
批准号:81072363
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:郑红
-
依托单位:
高原人群创伤性深静脉血栓血浆预测诊断蛋白标记物的发掘
-
批准号:81060151
-
项目类别:地区科学基金项目
-
资助金额:25.0万元
-
批准年份:2010
-
负责人:赵学凌
-
依托单位:
非小细胞肺癌Biomarker的Imaging MS研究新方法
-
批准号:30672394
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2006
-
负责人:陆豪杰
-
依托单位: